The Claim
Insulin receptors in breast cancer tissues retain functional integrity, including insulin binding capacity and insulin-induced tyrosine kinase activation, indicating potential biological activity in cancer cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In simple terms, this means that in breast cancer tissues, the parts that respond to insulin still work normally, which might help the cancer cells grow or function.
See the scientific wording
Insulin receptors in breast cancer tissues remain functionally intact, maintaining both insulin binding capability and insulin-induced tyrosine kinase activation, suggesting these receptors could be biologically active in cancer cells.
What the research says
1 studyStudy: Elevated insulin receptor content in human breast cancer.
The study found that breast cancer cells have more insulin receptors that still work properly, which matches the claim that these receptors are active in cancer.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.